{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T15:05:47Z","timestamp":1788015947634,"version":"build-2784847793"},"reference-count":69,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.cld.2020.04.004","type":"journal-article","created":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T07:48:24Z","timestamp":1590479304000},"page":"521-534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Acute on Chronic Liver Failure"],"prefix":"10.1016","volume":"24","author":[{"given":"Ariel","family":"Aday","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline G.","family":"O\u2019Leary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10201","key":"10.1016\/j.cld.2020.04.004_bib1","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0140-6736(19)31894-X","article-title":"Acute liver failure","volume":"394","author":"Stravitz","year":"2019","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.cld.2020.04.004_bib2","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jhep.2018.08.024","article-title":"Acute-on-chronic liver failure vs. traditional acute decompensation of cirrhosis","volume":"69","author":"Gustot","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2020.04.004_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.gastro.2014.05.005","article-title":"Toward an improved definition of acute-on-chronic liver failure","volume":"147","author":"Jalan","year":"2014","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2020.04.004_bib4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12072-008-9106-x","article-title":"Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)","volume":"3","author":"Sarin","year":"2009","journal-title":"Hepatol Int"},{"issue":"40","key":"10.1016\/j.cld.2020.04.004_bib5","doi-asserted-by":"crossref","first-page":"14934","DOI":"10.3748\/wjg.v20.i40.14934","article-title":"Chronic liver failure-Sequential organ failure assessment is better than the Asia-Pacific association for the study of liver criteria for defining acute-on-chronic liver failure and predicting outcome","volume":"20","author":"Dhiman","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.cld.2020.04.004_bib6","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2020.04.004_bib7","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/hep.27077","article-title":"Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures","volume":"60","author":"Bajaj","year":"2014","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2020.04.004_bib8","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1002\/hep.29773","article-title":"NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis","volume":"67","author":"O'Leary","year":"2018","journal-title":"Hepatology"},{"issue":"S1","key":"10.1016\/j.cld.2020.04.004_bib9","first-page":"1","article-title":"Oral abstracts (Abstract 284): validating the results of the NACSELD-ACLF score using a nationally-representative inpatient database","volume":"68","author":"Rosenblatt","year":"2018","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2020.04.004_bib10","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/lt.25443","article-title":"NASH is the most rapidly growing etiology for acute-on-chronic liver failure-related hospitalization and disease burden in the United States: a population-based study","volume":"25","author":"Axley","year":"2019","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.cld.2020.04.004_bib11","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1002\/hep.28812","article-title":"Time trends in the health care burden and mortality of acute on chronic liver failure in the United States","volume":"64","author":"Allen","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2020.04.004_bib12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/hep.28414","article-title":"The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis","volume":"64","author":"Bajaj","year":"2016","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2020.04.004_bib13","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/gutjnl-2016-312670","article-title":"Acute-on-chronic liver failure: an update","volume":"66","author":"Hernaez","year":"2017","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.cld.2020.04.004_bib14","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/hep.25947","article-title":"Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience","volume":"56","author":"Bajaj","year":"2012","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.cld.2020.04.004_bib15","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.cgh.2016.04.009","article-title":"Rates of and reasons for hospital readmissions in patients with cirrhosis: a multistate population-based cohort study","volume":"14","author":"Tapper","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2020.04.004_bib16","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jhep.2012.06.026","article-title":"Acute-on chronic liver failure","volume":"57","author":"Jalan","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2020.04.004_bib17","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0168-8278(12)60002-6","article-title":"Management of bacterial infections in cirrhosis","volume":"56","author":"Fernandez","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2020.04.004_bib18","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.cgh.2014.07.060","article-title":"Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosis","volume":"13","author":"O'Leary","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2020.04.004_bib19","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jhep.2018.10.027","article-title":"Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe","volume":"70","author":"Fernandez","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2020.04.004_bib20","doi-asserted-by":"crossref","first-page":"599","DOI":"10.14309\/ajg.0000000000000044","article-title":"Outcomes in patients with cirrhosis on primary compared to secondary prophylaxis for spontaneous bacterial peritonitis","volume":"114","author":"Bajaj","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.cld.2020.04.004_bib21","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/hep.22853","article-title":"Management of adult patients with ascites due to cirrhosis: an update","volume":"49","author":"Runyon","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2020.04.004_bib22","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/liv.12625","article-title":"Healthcare-associated and nosocomial bacterial infections in cirrhosis: predictors and impact on outcome","volume":"35","author":"Sargenti","year":"2015","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.cld.2020.04.004_bib23","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","article-title":"Altered profile of human gut microbiome is associated with cirrhosis and its complications","volume":"60","author":"Bajaj","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2020.04.004_bib24","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/j.jceh.2014.12.003","article-title":"Gut microbiota: its role in hepatic encephalopathy","volume":"5","author":"Rai","year":"2015","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2020.04.004_bib25","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s10620-010-1447-3","article-title":"Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8","volume":"56","author":"Shanab","year":"2011","journal-title":"Dig Dis Sci"},{"issue":"10","key":"10.1016\/j.cld.2020.04.004_bib26","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/MCG.0b013e31829006bb","article-title":"Decompensated cirrhotics have slower intestinal transit times as compared with compensated cirrhotics and healthy controls","volume":"47","author":"Chander Roland","year":"2013","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2020.04.004_bib27","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cgh.2018.08.008","article-title":"Altered microbiome in patients with cirrhosis and complications","volume":"17","author":"Acharya","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.cld.2020.04.004_bib28","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.cgh.2011.02.031","article-title":"Immune dysfunction and infections in patients with cirrhosis","volume":"9","author":"Bonnel","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2020.04.004_bib29","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.cgh.2018.07.022","article-title":"Association between intestinal microbiota collected at hospital admission and outcomes of patients with cirrhosis","volume":"17","author":"Bajaj","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.cld.2020.04.004_bib30","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","article-title":"The gut-liver axis and the intersection with the microbiome","volume":"15","author":"Tripathi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2020.04.004_bib31","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4254\/wjh.v7.i3.425","article-title":"Gut-liver axis in liver cirrhosis: how to manage leaky gut and endotoxemia","volume":"7","author":"Fukui","year":"2015","journal-title":"World J Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2020.04.004_bib32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/jgh.12667","article-title":"Use of proton pump inhibitors decrease cellular oxidative burst in patients with decompensated cirrhosis","volume":"30","author":"Garcia-Martinez","year":"2015","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.cld.2020.04.004_bib33","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/apt.12045","article-title":"Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis","volume":"36","author":"Bajaj","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.cld.2020.04.004_bib34","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/s41395-018-0085-9","article-title":"Proton pump inhibitor initiation and withdrawal affects gut microbiota and readmission risk in cirrhosis","volume":"113","author":"Bajaj","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2020.04.004_bib35","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jhep.2015.10.018","article-title":"Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure","volume":"64","author":"Mookerjee","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2020.04.004_bib36","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases","volume":"65","author":"Garcia-Tsao","year":"2017","journal-title":"Hepatology"},{"issue":"10181","key":"10.1016\/j.cld.2020.04.004_bib37","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(18)31875-0","article-title":"Beta blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial","volume":"393","author":"Villanueva","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.cld.2020.04.004_bib38","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cgh.2019.05.050","article-title":"Lowering portal pressure improves outcomes of patients with cirrhosis, with or without ascites: a meta-analysis","volume":"18","author":"Turco","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2020.04.004_bib39","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.23775","article-title":"Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites","volume":"52","author":"Serste","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2020.04.004_bib40","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/apt.14366","article-title":"Beta-blockers in hospitalised patients with cirrhosis and ascites: mortality and factors determining discontinuation and reinitiation","volume":"47","author":"Bhutta","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.cld.2020.04.004_bib41","first-page":"20","article-title":"Beta-blockers in liver cirrhosis","volume":"27","author":"Giannelli","year":"2014","journal-title":"Ann Gastroenterol"},{"issue":"6","key":"10.1016\/j.cld.2020.04.004_bib42","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s12072-019-09986-9","article-title":"Treatment with carvedilol improves survival of patients with acute-on-chronic liver failure: a randomized controlled trial","volume":"13","author":"Kumar","year":"2019","journal-title":"Hepatol Int"},{"issue":"5","key":"10.1016\/j.cld.2020.04.004_bib43","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jhep.2012.12.011","article-title":"Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis","volume":"58","author":"Reiberger","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2020.04.004_bib44","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jhep.2014.12.029","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites","volume":"62","author":"Angeli","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2020.04.004_bib45","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1053\/j.gastro.2013.08.051","article-title":"New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection","volume":"145","author":"Wong","year":"2013","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2020.04.004_bib46","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jhep.2014.10.047","article-title":"A\u00a0cut-off serum creatinine value of 1.5\u00a0mg\/dL for AKI--to be or not to be","volume":"62","author":"Wong","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"7","key":"10.1016\/j.cld.2020.04.004_bib47","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/ajg.2017.122","article-title":"Acute kidney injury in cirrhosis: baseline serum creatinine predicts patient outcomes","volume":"112","author":"Wong","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2020.04.004_bib48","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1053\/j.gastro.2010.07.043","article-title":"Prognostic importance of the cause of renal failure in patients with cirrhosis","volume":"140","author":"Martin-Llahi","year":"2011","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.cld.2020.04.004_bib49","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1111\/ajt.15559","article-title":"The decreasing predictive power of MELD in an era of changing etiology of liver disease","volume":"19","author":"Godfrey","year":"2019","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.cld.2020.04.004_bib50","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jhep.2012.01.012","article-title":"Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study","volume":"56","author":"Singh","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"9","key":"10.1016\/j.cld.2020.04.004_bib51","article-title":"Terlipressin versus other vasoactive drugs for hepatorenal syndrome","author":"Israelsen","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.cld.2020.04.004_bib52","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2215\/CJN.03610417","article-title":"Prognosis of patients with cirrhosis and AKI who initiate RRT","volume":"13","author":"Allegretti","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"23","key":"10.1016\/j.cld.2020.04.004_bib53","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa1703058","article-title":"Time to treatment and mortality during mandated emergency care for sepsis","volume":"376","author":"Seymour","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.cld.2020.04.004_bib54","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.14309\/ajg.0000000000000280","article-title":"Nosocomial infections are frequent and negatively impact outcomes in hospitalized patients with cirrhosis","volume":"114","author":"Bajaj","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2020.04.004_bib55","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1172\/JCI101711","article-title":"Chemical, clinical and immunologic studies on the produce of human plasma fractionation. The use of salt-poor concentrated human serum albumin solution in the treatment of hepatic cirrhosis","volume":"25","author":"Gw","year":"1946","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1016\/j.cld.2020.04.004_bib56","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.26338","article-title":"Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications","volume":"58","author":"Garcia-Martinez","year":"2013","journal-title":"Hepatology"},{"issue":"10138","key":"10.1016\/j.cld.2020.04.004_bib57","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/S0140-6736(18)30840-7","article-title":"Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial","volume":"391","author":"Caraceni","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cld.2020.04.004_bib58","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.gastro.2019.03.021","article-title":"Effects of albumin treatment on systemic and portal hemodynamics and systemic inflammation in patients with decompensated cirrhosis","volume":"157","author":"Fernandez","year":"2019","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2020.04.004_bib59","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jhep.2012.06.013","article-title":"Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study","volume":"57","author":"Guevara","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"9","key":"10.1016\/j.cld.2020.04.004_bib60","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/s41395-018-0119-3","article-title":"The impact of albumin use on resolution of hyponatremia in hospitalized patients with cirrhosis","volume":"113","author":"Bajaj","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2020.04.004_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/hep.31071","article-title":"Paracentesis-induced circulatory dysfunction with modest-volume paracentesis is partly ameliorated by albumin infusion in ACLF","author":"Arora","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2020.04.004_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2019.09.035","article-title":"Including relative adrenal insufficiency in definition and classification of acute-on-chronic liver failure","author":"Piano","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2020.04.004_bib63","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/liv.13355","article-title":"Impact of acute-on-chronic liver failure on 90-day mortality following a first liver transplantation","volume":"37","author":"Levesque","year":"2017","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.cld.2020.04.004_bib64","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jhep.2018.12.018","article-title":"Prevalence and short-term mortality of acute-on-chronic liver failure: a national cohort study from the USA","volume":"70","author":"Hernaez","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"9","key":"10.1016\/j.cld.2020.04.004_bib65","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cgh.2013.03.035","article-title":"Factors that predict short-term intensive care unit mortality in patients with cirrhosis","volume":"11","author":"Bahirwani","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2020.04.004_bib66","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jhep.2017.06.009","article-title":"Liver transplantation in the most severely ill cirrhotic patients: a multicenter study in acute-on-chronic liver failure grade 3","volume":"67","author":"Artru","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2020.04.004_bib67","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/hep.27849","article-title":"Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis","volume":"62","author":"Gustot","year":"2015","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2020.04.004_bib68","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/lt.25426","article-title":"Outcomes after listing for liver transplant in patients with acute-on-chronic liver failure: the Multicenter North American Consortium for the study of end-stage liver disease experience","volume":"25","author":"O'Leary","year":"2019","journal-title":"Liver Transpl"},{"issue":"11","key":"10.1016\/j.cld.2020.04.004_bib69","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1111\/apt.14627","article-title":"Stabilisation of acute-on-chronic liver failure patients before liver transplantation predicts post-transplant survival","volume":"47","author":"Huebener","year":"2018","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326120300295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326120300295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:56:32Z","timestamp":1761069392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326120300295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1089326120300295"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2020.04.004","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute on Chronic Liver Failure","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2020.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}